158 related articles for article (PubMed ID: 38779517)
1. Ultrasonography of Hepatocellular Carcinoma: From Diagnosis to Prognosis.
Hu H; Zhao Y; He C; Qian L; Huang P
J Clin Transl Hepatol; 2024 May; 12(5):516-524. PubMed ID: 38779517
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis.
Jiang HY; Chen J; Xia CC; Cao LK; Duan T; Song B
World J Gastroenterol; 2018 Jun; 24(22):2348-2362. PubMed ID: 29904242
[TBL] [Abstract][Full Text] [Related]
3. Current role of ultrasound in the diagnosis of hepatocellular carcinoma.
Tanaka H
J Med Ultrason (2001); 2020 Apr; 47(2):239-255. PubMed ID: 32170489
[TBL] [Abstract][Full Text] [Related]
4. Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: imaging diagnosis and staging of hepatocellular carcinoma.
Choi BI; Lee JM
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):369-73. PubMed ID: 19967573
[TBL] [Abstract][Full Text] [Related]
5. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
6. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review.
Shahini E; Pasculli G; Solimando AG; Tiribelli C; Cozzolongo R; Giannelli G
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901717
[TBL] [Abstract][Full Text] [Related]
7. Application of Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) in hepatocellular carcinoma.
Li XQ; Wang X; Zhao DW; Sun J; Liu JJ; Lin DD; Yang G; Liu H; Xia ZY; Jia CY; Li HJ
World J Surg Oncol; 2020 Aug; 18(1):219. PubMed ID: 32828123
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinoma.
Song P; Tang Q; Feng X; Tang W
Scand J Clin Lab Invest Suppl; 2016; 245():S70-6. PubMed ID: 27438343
[TBL] [Abstract][Full Text] [Related]
9. Current status of hepatocellular carcinoma detection: screening strategies and novel biomarkers.
Ayoub WS; Steggerda J; Yang JD; Kuo A; Sundaram V; Lu SC
Ther Adv Med Oncol; 2019; 11():1758835919869120. PubMed ID: 31523283
[TBL] [Abstract][Full Text] [Related]
10. Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it?
Giannini EG; Cucchetti A; Erroi V; Garuti F; Odaldi F; Trevisani F
World J Gastroenterol; 2013 Dec; 19(47):8808-21. PubMed ID: 24379604
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular Carcinoma: Current Concepts in Diagnosis, Staging and Treatment.
Schütte K; Schulz C; Malfertheiner P
Gastrointest Tumors; 2014 Jun; 1(2):84-92. PubMed ID: 26672483
[TBL] [Abstract][Full Text] [Related]
12. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.
Wang CH; Wey KC; Mo LR; Chang KK; Lin RC; Kuo JJ
Asian Pac J Cancer Prev; 2015; 16(9):3595-604. PubMed ID: 25987009
[TBL] [Abstract][Full Text] [Related]
13. Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience.
Maruyama H; Sekimoto T; Yokosuka O
J Gastroenterol; 2016 May; 51(5):421-33. PubMed ID: 26694825
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Fraquelli M; Nadarevic T; Colli A; Manzotti C; Giljaca V; Miletic D; Štimac D; Casazza G
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013483. PubMed ID: 36053210
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
Hanouneh IA; Alkhouri N; Singal AG
Clin Mol Hepatol; 2019 Sep; 25(3):264-269. PubMed ID: 30827081
[TBL] [Abstract][Full Text] [Related]
16. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
[TBL] [Abstract][Full Text] [Related]
17. B-Mode Ultrasonography versus Contrast-Enhanced Ultrasonography for Surveillance of Hepatocellular Carcinoma: A Prospective Multicenter Randomized Controlled Trial.
Kudo M; Ueshima K; Osaki Y; Hirooka M; Imai Y; Aso K; Numata K; Kitano M; Kumada T; Izumi N; Sumino Y; Ogawa C; Akazawa K
Liver Cancer; 2019 Jul; 8(4):271-280. PubMed ID: 31602370
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.
Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Han K; Nam CM; Park SH; Lee KH
BMC Cancer; 2017 Apr; 17(1):279. PubMed ID: 28420329
[TBL] [Abstract][Full Text] [Related]
19. Predictive Value of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Early Recurrence of Hepatocellular Carcinoma after Surgical Resection.
Wang Y; Liao J; Qi W; Xie L; Li Y
Ultrasound Med Biol; 2016 May; 42(5):1042-8. PubMed ID: 26803390
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma surveillance: current practice and future directions.
Ahn JC; Lee YT; Agopian VG; Zhu Y; You S; Tseng HR; Yang JD
Hepatoma Res; 2022; 8():. PubMed ID: 36161213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
